Alumis Shares Plummet 59% After Lupus Study Failure Wipes Out $1.67 Billion

Shares of Alumis Inc. dropped 59.2% to $8.89 after the company reported its lupus trial failed to meet its main and secondary endpoints. As of 11:32:55 EDT, trading volume was 13.97 million shares.

Category hubBreaking

Breaking News & Analysis

Follow the latest TS2 Tech reporting, investor analysis and material developments for Breaking in one continuously updated topic hub.

Save this hub to your private article dashboard.
Latest update
Sep 1, 2026
Articles in this hub
20
Last 30 days
20

What this hub covers

  • Latest news and material developments
  • Key data, catalysts and investor context
  • Market reaction and emerging themes